Savara Inc (SVRA) CEO Robert N Neville Bought $248,188 of Shares
- By insider
CEO of Savara Inc (SVRA) Robert N Neville bought 52,250 shares of SVRA on 06/07/2017 at an average price of $4.75 a share. The total cost of this purchase was $248,188.
Savara Inc is a clinical-stage specialty pharmaceutical company focused on the development and commercialization of novel therapies for the treatment of serious or life-threatening rare respiratory diseases. Savara Inc has a market cap of $140.030 million; its shares were traded at around $5.79 with and P/S ratio of 89.02.
Warning! GuruFocus has detected 1 Warning Sign with SVRA. Click here to check it out.
The intrinsic value of SVRA
CEO Recent Trades:
CEO Robert N Neville bought 52,250 shares of SVRA stock on 06/07/2017 at the average price of $4.75. The price of the stock has increased by 21.89% since.
CFO Recent Trades:
CFO David L Lowrance bought 2,100 shares of SVRA stock on 06/07/2017 at the average price of $4.75. The price of the stock has increased by 21.89% since.
Directors and Officers Recent Trades:
Director David A Ramsay bought 21,000 shares of SVRA stock on 06/07/2017 at the average price of $4.75. The price of the stock has increased by 21.89% since.
Director Yuri Pikover bought 100,000 shares of SVRA stock on 06/07/2017 at the average price of $4.75. The price of the stock has increased by 21.89% since.
See Remarks Jaakko Taneli Jouhikainen bought 10,500 shares of SVRA stock on 06/07/2017 at the average price of $4.75. The price of the stock has increased by 21.89% since.
Director Joseph S Mccracken bought 52,250 shares of SVRA stock on 06/07/2017 at the average price of $4.75. The price of the stock has increased by 21.89% since.
For the complete insider trading history of SVRA, click here
.This article first appeared on GuruFocus.
Warning! GuruFocus has detected 1 Warning Sign with SVRA. Click here to check it out.
The intrinsic value of SVRA